Co gets FDA nod for four generics

NEW DELHI: Drug major Sun Pharmaceutical industries on Wednesday said the company, along with its subsidiary, has received abbreviated new drug application (ANDA) approval for four generic products from the US health regulator.

The company has received approvals from the US FDA for generic Hydrocodone Bitarlate with Acetaminophen tablets, generic Aredia Pamidronate Disodium injections, generic Lopid Gemfibrozil tablets and generic Phenargan Promethazine Hydrochloride tablets in various strengths, Sun said in a statement.